Sonic Healthcare Limited (OTCMKTS:SKHHY - Get Free Report) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 6,600 shares, a decline of 54.2% from the May 15th total of 14,400 shares. Currently, 0.0% of the company's stock are short sold. Based on an average trading volume of 66,800 shares, the days-to-cover ratio is presently 0.1 days.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on SKHHY. The Goldman Sachs Group upgraded Sonic Healthcare to a "strong-buy" rating in a research note on Friday, April 4th. Morgan Stanley set a $28.10 price target on Sonic Healthcare in a research report on Wednesday, March 19th.
Check Out Our Latest Stock Report on Sonic Healthcare
Sonic Healthcare Stock Performance
OTCMKTS SKHHY traded down $0.35 during trading on Tuesday, hitting $17.21. 100,691 shares of the stock traded hands, compared to its average volume of 51,666. The firm has a 50-day simple moving average of $16.85 and a 200-day simple moving average of $17.09. Sonic Healthcare has a 12-month low of $14.47 and a 12-month high of $20.59.
About Sonic Healthcare
(
Get Free Report)
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.
Featured Articles
Before you consider Sonic Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonic Healthcare wasn't on the list.
While Sonic Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.